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Relationship between Adiponectin and different clinical types of
Coronary heart disease
Hongjun Liu
Huanyuan County The second people Hospital
OBJECTIVES Cathepsin L (CATL) is a kind of papain family of ho-
mocysteine proteolytic enzymes in the form of enzymes, and stored in
the lysosome, It can produce the risk of cardiovascular diseases in
human, which of the mechanism is not fully established. Higher CATL
concentration is associate of cardiovascular events. So, for the past
few years, scholars pay more attention to the factor. There is not
plenty of studies in China, however, in west countries, there are
adequate evidences from animal and human studies. But the role of
CATL in coronary heart disease remains to be established and need
further more researches to conﬁrm.
METHODS Coronary angiography (CAG) was performed in 64 hospitalized
patients suspected as having coronary heart disease(CHD). Patients who
were conﬁrmedwith CHDwere internalized toCHDgroup(n¼64); andnon-
CHD group as control group(n¼26). The CHD group were further divided
into 3 subgroups, they are:stable angina pectoris(SAP, n¼27); unstable
angina pectoris(UAP, n¼23) and acute myocardial infarction(AMI, n¼14).
Enzyme linked immunosorbent assay were made use of to detect the mass
of CATL and the concentration of hs-CRP. The corresponding data was
analyzed by SPSS 17.0 software.
RESULTS (1) Plasma CATL concentration in CHD group are higher
than in the control group(4543.161444.29 vs 1654.16154.16ng/mL,
P<0.05);plasma CATL mass in SAP were higher than in control
group(2942.74280.62 vs 1654.16154.16 ng/mL, P<0.05); Plasma
CATL mass in UAP were higher than SAP group (5479.38485.60 vs
2942.74280.62 ng/mL, P<0.05); plasma CATL mass in AMI were
higher than in UAP group(6091.70315.52 vs 5479.38485.60ng/mL,
P<0.05); Plasma hs-CRP concentration in SAP group are higher than
control group (1.440.29 vs 0.380.22 mg/L, P<0.05); Plasma hs-CRP
mass in UAP group are also higher than SAP group (4.160.54 vs
1.440.29 mg/L, P<0.05) Plasma hs-CRP mass in AMI group are also
higher than UAP group (6.000.90 vs 4.160.54mg/L, P<0.05) (2)
CATL was closely related in Gensini score(r¼0.39, P<0.05). (3) Plasma
CATL concentration was Positively correlated with TC, TG, and non-
correlated with high blood pressure. Hs-CRP was not an independent
risk factor for coronary heart disease, but CATL had an independent
relationship with coronary heart disease.
CONCLUSIONS 1. Relation of plasma CATL concentration to the sub-
groups of CHD: CATL density were gradually increase from SAP, UAP
to AMI; The trend may mention that CATL may be a productive factor.
2. Relation of plasma hs-CRP concentration to CHD: the subgroups of
CHD group, hs-CRP density were gradually increase from SAP, UAP to
AMI; The trend may mention that CATL may be a damage factor. 3.
There were positive correlation between plasma CATL concentration
and plasma hs-CRP concentration.
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A cohort study of early cardiologist consultation by telemedicine on the
critical Non-STEMI inpatients
Wisit Wichitkosoom, Suwanna Nathee
Cardiac Center, Udonthani General Hospital
OBJECTIVES To ﬁnd out the more effect of early cardiologist
consultation using a simple technology on the diagnosis and early
proper management of patients with Non-STEMI at emergency
department of district hospitals without cardiologist on site before
transferred.
METHODS A cohort study was performed in Udonthani general hos-
pital at Udonthani province. From 1 October 2012 – 30 September 2013
with 892 patients diagnosed with Non-STEMI. All patients mean aged
46.8 years of age who had been transferred because of Non-STEMI
diagnosed, over a 12 week period of studied. Patients whose trans-
ferred, in addition to receiving proper care, were offered a cardiologist
consultation with average time to Udonthani hospital 1.5 hour. The
main outcome measure was length of hospital stay, mortality at 3
months, inpatient investigation, and transfer rate to the higher facil-
itated hospital were also studied.
RESULTS Hospital stay was signiﬁcantly shorter for those didn’t
consult cardiologist (hazard ratio 1.19; approximate 95% CI 1.001 to
1.251; p ¼ 0.039). The 136 cases were transferred to higher facilitated
hospital. No statistically signiﬁcant in overall mortality between the
groups (p¼0.068).CONCLUSIONS Early cardiologist consultant can reduce length of
hospital stay for patients with cardiovascular conditions outside of
cardiac center. The new basic technology can apply for the safety
patient.GW26-e3602
Effect of different intervening models in improving medication adherence
of ACS patients : Results from the Bridging the Gap on CHD Secondary
Prevention in China (BRIG) project
Wei Wang, Jun Liu, Jing Liu, Ying Wang, Jiayi Sun, Dong Zhao
Department of Epidemiology, Beijing An Zhen Hospital, Capital
Medical University, Beijing Institute of Heart, Lung and Blood Vessel
Diseases
OBJECTIVES Medication of four evidence-based drugs, including
anti-platelet agent, statins, b-blockers and angiotensin converting
enzyme (ACE) inhibitor can effectively improve the prognosis of pa-
tients with acute coronary syndrome (ACS). The study aims to eval-
uate the outcome of the intervening measures (the handout of the
promotional materials and/or publicity and education about second-
ary prevention from nurses) for hospitalized ACS patients in
improving post-discharge medication adherence of ACS patients.
METHODS Thirty-four hospitals from 21 provinces in China partici-
pated in this study. All the hospitals were randomly divided into four
groups: one control group (Group 1) who received routine care and
three intervention groups. Group 2 was provided with the promo-
tional materials, and Group 3 got the publicity and education about
secondary prevention from nurses, and Group 4 received the com-
bined intervention measures of Groups 2 and 3. The ACS patients of
three intervention groups were interfered in hospitalization. All the
ACS patients were followed up for 6 months after discharge.
RESULTS Two thousand two hundred and forty-four patients were
included for analysis after the four groups went through Propensity
Score.
1) Among the use of four evidence-based medicines for secondary
prevention, the administration rates of anti-platelet, statins, ACEI/
ARB and the combination of the four medicines were 98.3w94.9%,
93.0w88.6%, 60% and 45.9%, respectively.
2) The follow-up of ACS patients conducted at 6 months after
discharge displayed that, the medicine adherence rates in Groups 3
and 4 were higher than that in Group 1 and the differences were sta-
tistically signiﬁcant.
A multiple-factor analysis indicated that the combined intervention
group had the highest medicine adherence rate, and the administra-
tion rate of the combination of the four medicines was 19% higher
than that of the control group (P<0.05). 3) Control rate of LDL-
C <100mg/dl at six months after discharge was the highest (69.6%) in
the combined intervention group. Control rates of blood
pressure <140/90mmHg in Groups 3 and 4 were higher than that in
Group 1, and had statistical differences.
CONCLUSIONS Combined intervening measures of the handout of
promotional materials and the publicity and education about sec-
ondary prevention from nurses during hospitalization can improve
post-discharge medication adherence of ACS patients. Combined
intervention plays a better effect compared with the handout of pro-
motional materials or the publicity and education about secondary
prevention from nurses alone. This method is simple and easy to
perform and would give a positive reference to the medication
adherence for secondary prevention drugs of the current coronary
heart disease in China.GW26-e0189
Intra-aortic balloon pump is irrelevant to the short and long term mortality
rate of patients with acute myocardial infarction
Dan Su,1 Bin Yan,2 Liyuan Peng,2 Gang Wang2
1Department of Cardiology, the Second Afﬁliated Hospital, Xi’an
Jiaotong University School of Medicine, Xi’an, China; 2Department of
Emergency Medicine, the Second Afﬁliated Hospital, Xi’an Jiaotong
University School of Medicine, Xi’an, China
OBJECTIVES Intra-aortic balloon pump (IABP) has been extensively
used in clinical practice as a circulatory-assist device. However, the
efﬁcacy of IABP has been doubted since its ﬁrst application during
the early 1960s. Current literature demonstrates wide inconsistency of
the indications for IABP utilization and outcomes. The aim of our
current updated meta-analysis was to assess the potential beneﬁts of
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cardiogenic shock from all published randomized trials (RCTs) to date.
METHODS To identify all RCTs of IABP therapy, public databases
including MEDLINE (1966 to 2014) and EMBASE (1980 to 2014) were
searched. The search was restricted to human studies and clinical
trials or randomized controlled trials only. In addition, we also
manually searched bibliographies of identiﬁed studies if needed.
References were screened for studies that compared the use of IABP in
AMI with or without cardiogenic shock. Data extraction was carried
out independently and in duplicates.
RESULTS Seventeen relevant studies met the inclusion criteria and
3226 participants were enrolled in our study after in-depth review. We
analyzed the impact of IABPmanagement on short-termmortality in 14
trials (2354 patients), long-term mortality in 9 trials (1743 patients).
There was no signiﬁcant difference on short-term mortality (less than
30-day mortality) between IABP on AMI patients with cardiogenic
shock and control group (RR, 0.91; 95% CI, 0.77–1.08; P¼0.293). Similar
result was also observed in AMI patients without cardiogenic shock
(RR, 0.88; 95% CI, 0.60–1.29; P¼0.279). Taken together, the short-term
mortality of patients with AMI with and without cardiogenic shock
does not differ between IABP and control group (RR, 0.90; 95%CI, 0.77–
1.06; p¼0.214). Interestingly, further analysis of two subgroups in 9
studies (4 AMI trials with cardiogenic shock and 5 without cardiogenic
shock) also demonstrated that IABP therapy was not associated with a
signiﬁcantly reduced risk of long-term mortality (6- and 12-month
mortality) rate (RR, 0.91; 95% CI, 0.79–1.04; P ¼0.155). Similar results
were shown when the analyses were performed on patients with (RR,
0.95; 95% CI, 0.83–1.10; P¼0.492) or without cardiogenic shock (RR,
0.73; 95% CI, 0.49–1.09; P¼0.122), respectively.
CONCLUSIONS As far as we know, this is the ﬁrst updated meta-
analysis of only randomized controlled trials including IABP-SHOCK II
trial. We did not observe substantial beneﬁt from IABP use in AMI
patients with or without cardiac shock in reducing the short-term and
long-term mortality rate. However, AMI is not only associated with
compromised cardiac contractile function, especially in patients with
cardiogenic shock. Other than mortality, more comprehensive
assessment of hemodynamic changes or laboratory inﬂammatory
markers may serve as better end points. Therefore, future RCTs with
larger numbers of patients and rigorous design are required.
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Relationship Between Myocardial Perfusion and Vascular Endothelial
Function in Patients with Non-ST-Segment Elevation Acute Coronary
Syndrome
Weiyi Mei
Department of Cardiology, the Eastern Hospital of the First Afﬁliated
Hospital, Sun Yat-Sen University, Guangzhou 510700, China
OBJECTIVES Endothelial function plays a key role in determining the
clinical manifestations of atherosclerotic lesions. This study aimed to
investigate the relationship between endothelial function and
myocardial perfusion before or after percutaneous coronary inter-
vention (PCI) in patients with non-ST-elevation acute coronary syn-
drome (NSTE-ACS).
METHODS 172 patients, with high-risk NSTE-ACS were measured
levels nitric oxide (NO) and endothelin (ET), and detected the brachial
artery ﬂow-mediated vasodilation (FMD) before PCI. The angiographic
data was analyzed before and after PCI, in terms of TIMI myocardial
perfusion grade in the area of culprit vessels.
RESULTS Before PCI, 78 patients with TMPG 1w2 had lower NO levels
(44.16mmol/L7.46mmol/L vs. 52.25mmol/L5.17mmol/L, P¼0.042),
and lower FMD (2.261.83% vs. 3.451.43%, P¼0.028) than those with
TMPG 2w3, while the levels of ET were not different (p¼0.462). After
PCI, 47 patients with TMPG 1w2 had lower NO levels (42.64mmol/
L8.58mmol/L vs. 54.87mmol/L7.30mmol/L, P¼0.031), and lower FMD
(2.031.25% vs. 3.661.38%, P¼0.020) than those with TMPG 2w3.
CONCLUSIONS Lower NO levels and lower FMD can be measured
before PCI in those high-risk NSTE-ACS patients with poor myocardial
perfusion pre- or post-PCI, which indicated more damaged endothe-
lial function in poor myocardial perfusion patients with NSTE-ACS.
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Fractional Flow Reserve Guided Percutaneous Coronary Intervention
improves clinical outcome with reduced cost in Chinese real world practice
Po Hu,1,2 Mengyao Tang,2 Wenchao Song,2 Jun Jiang,1,2 Yong Su,1,2
Xianbao Liu,1,2 Changling L,1,2 Xinyang Hu,1,2 Jianan Wang1,2
1Department of Cardiology, Second Afﬁliated Hospital, College ofMedicine, Zhejiang University, Hangzhou, PR China; 2Cardiovascular
Key Laboratory of Zhejiang Province, Hangzhou, PR China
OBJECTIVES Fractional ﬂow reserve (FFR) is currently considered the
gold standard for evaluating the functional signiﬁcance of coronary
stenosis. However, its potential beneﬁts in real-world practice remain
unknown in China.
METHODS A retrospective cohort study was carried out using the
EMRS database of The Second Afﬁliated Hospital of Zhejiang Univer-
sity, a tertiary and high-volume center in China. Clinical events were
compared using the Cox proportional hazards model during a median
follow-up of 13 months.
RESULTS The study cohort consisted of 366 consecutive patients
referred for coronary revascularization with adjunct FFR and 366
matched controls, from 2010 to 2014. Major adverse cardiac events
(death, myocardial infarction, repeated revascularization, or hospi-
talization for angina) at 4 years were found in 12.0% of angiography-
guided patients and 4.9% in the FFR-guided group (p<0.001). The
mean number of implanted stents was signiﬁcantly lower in FFR
treated subjects (0.520.82 stents) compared with the angiography-
guided group (0.930.96 stents) (P<0.001). No difference in overall
costs at initial hospitalization was observed between angiography-
guided percutaneous coronary intervention (PCI) compared with
FFR-guided PCI (￥33000, range 7393-44700) versus￥21200 (￥19100-
47100) (p¼0.54). How ever, mean costs for major adverse cardiac
events during follow-up were signiﬁcantly reduced in the FFR-guided
arm (￥1688 9554 versus ￥344112873, p<0.001).
CONCLUSIONS In the contemporary clinical practice, FFR-guided PCI
is associated with decreased use of stents, improved clinical outcome,
and reduced costs, compared with angiography-guided PCI.GW26-e4423
Analysis of the risk factors and characteristics of coronary artery disease of
Han, Uygur and Kazak patients with acute myocardial infarction in Xinjiang
Jiao Wang Muhuyati
Cardiac Center, the First Afﬁliated Hospital of Xinjiang Medical
university, Urumqi 830011, China
OBJECTIVES To discuss the risk factors and characteristics of coro-
nary artery disease of Han, Uygur and Kazak patients with acute
myocardial infarction in Xinjiang district.
METHODS A retrospective analysis of clinical data of 262 cases of Han
patients, 166 cases of Uygur patients and 86 cases of Kazak patients
was conducted, whose age, body mass index, cholesterol, uric acid,
hypertension, type 2 diabetes, smoking, drinking, family history of
coronary heart disease, relationship between PCI history and patho-
genesis of acute myocardial infarction, and coronary artery disease
characteristics were observed and compared in different groups.
RESULTS Between the Han and minority young patients, there were
statistically signiﬁcant differences in the distribution of BMI, lipo-
protein a, positive family history of coronary heart disease, uric acid
level, the combined aspects of smoking history (P <0.017); there were
also statistically signiﬁcant differences in BMI, TG, HDL-C, apolipo-
protein B, positive family history of coronary heart disease distribu-
tion between minority young patients and older patients (P <0.017).
There were statistically signiﬁcant differences in the distribution of
BMI, TC, HDL-C, LDL-C, apolipoprotein AI, positive family history of
coronary heart disease between Han and Uygur patients (P <0.017).
Han and Kazak patients had statistically signiﬁcant differences in the
distribution of BMI, TC, LDL-C, apolipoprotein B, lipoprotein a, type 2
diabetes and hypertension (P <0.017). Comparison of patients in
Uygur and Kazak showed that there were statistically signiﬁcant dif-
ferences in the distribution of BMI, TC, LDL-C, apolipoprotein AI,
apolipoprotein B and type 2 diabetes between the two groups
(P <0.017). The proportion of zero lesions and single-vessel lesions in
minority youth patients was higher than that of elderly patients
(P <0.001), and the proportion of two and three lesions was less than
that of elderly patients (P <0.001). Gensini score of Han patients was
greater than that of Uygur patients (P <0.001) and the Kazak patients
(P ¼ 0.005); The proportion of Han patients with single-vessel disease
was less than that of Kazak patients (P ¼ 0.003), and the proportion of
patients with double-vessel disease was greater than that of Kazak
patients (P ¼ 0.007). The logistic show that: the risk factors of mi-
nority youth are TG (OR ¼30.793), smoking (OR ¼6.203), hypertension
(OR ¼4.49), hyperuricemia (OR¼2.913) (P <0.05).
CONCLUSIONS There were ethnic differences in risk factors and the
characteristics of coronary artery disease of AMI patients in Xinjiang
